Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | yes | yes: 7 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 14 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:1990904 | ribonucleoprotein complex | 2 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0003729 | mRNA binding | 5 | 2 |
GO:0005488 | binding | 1 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 66 | 70 | PF00656 | 0.473 |
CLV_NRD_NRD_1 | 86 | 88 | PF00675 | 0.304 |
CLV_PCSK_KEX2_1 | 86 | 88 | PF00082 | 0.300 |
CLV_PCSK_SKI1_1 | 111 | 115 | PF00082 | 0.342 |
CLV_PCSK_SKI1_1 | 116 | 120 | PF00082 | 0.342 |
CLV_PCSK_SKI1_1 | 201 | 205 | PF00082 | 0.480 |
CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.425 |
CLV_PCSK_SKI1_1 | 8 | 12 | PF00082 | 0.763 |
DOC_CYCLIN_yCln2_LP_2 | 177 | 183 | PF00134 | 0.509 |
DOC_MAPK_gen_1 | 86 | 95 | PF00069 | 0.501 |
DOC_MAPK_MEF2A_6 | 196 | 204 | PF00069 | 0.483 |
DOC_PP2B_LxvP_1 | 119 | 122 | PF13499 | 0.618 |
DOC_PP4_FxxP_1 | 139 | 142 | PF00568 | 0.429 |
DOC_USP7_MATH_1 | 50 | 54 | PF00917 | 0.713 |
DOC_USP7_UBL2_3 | 11 | 15 | PF12436 | 0.570 |
DOC_USP7_UBL2_3 | 124 | 128 | PF12436 | 0.535 |
DOC_USP7_UBL2_3 | 19 | 23 | PF12436 | 0.659 |
DOC_USP7_UBL2_3 | 33 | 37 | PF12436 | 0.571 |
DOC_USP7_UBL2_3 | 4 | 8 | PF12436 | 0.674 |
DOC_WW_Pin1_4 | 123 | 128 | PF00397 | 0.559 |
DOC_WW_Pin1_4 | 138 | 143 | PF00397 | 0.496 |
DOC_WW_Pin1_4 | 176 | 181 | PF00397 | 0.504 |
LIG_14-3-3_CanoR_1 | 145 | 154 | PF00244 | 0.481 |
LIG_14-3-3_CanoR_1 | 196 | 201 | PF00244 | 0.525 |
LIG_APCC_ABBA_1 | 105 | 110 | PF00400 | 0.511 |
LIG_BRCT_BRCA1_1 | 135 | 139 | PF00533 | 0.439 |
LIG_BRCT_BRCA1_1 | 140 | 144 | PF00533 | 0.431 |
LIG_FHA_1 | 115 | 121 | PF00498 | 0.568 |
LIG_FHA_1 | 197 | 203 | PF00498 | 0.517 |
LIG_FHA_1 | 62 | 68 | PF00498 | 0.607 |
LIG_LIR_Apic_2 | 136 | 142 | PF02991 | 0.425 |
LIG_LIR_LC3C_4 | 117 | 121 | PF02991 | 0.693 |
LIG_LIR_Nem_3 | 155 | 160 | PF02991 | 0.591 |
LIG_SH2_CRK | 90 | 94 | PF00017 | 0.500 |
LIG_SH2_NCK_1 | 90 | 94 | PF00017 | 0.500 |
LIG_SH2_SRC | 176 | 179 | PF00017 | 0.430 |
LIG_SH2_SRC | 90 | 93 | PF00017 | 0.465 |
LIG_SH2_STAP1 | 90 | 94 | PF00017 | 0.500 |
LIG_SH2_STAT5 | 176 | 179 | PF00017 | 0.423 |
LIG_SH2_STAT5 | 58 | 61 | PF00017 | 0.525 |
LIG_SH3_3 | 6 | 12 | PF00018 | 0.685 |
LIG_SH3_4 | 11 | 18 | PF00018 | 0.780 |
LIG_SH3_4 | 19 | 26 | PF00018 | 0.777 |
LIG_SH3_4 | 33 | 40 | PF00018 | 0.756 |
LIG_SUMO_SIM_anti_2 | 117 | 122 | PF11976 | 0.663 |
LIG_TRAF2_1 | 214 | 217 | PF00917 | 0.543 |
MOD_CDK_SPK_2 | 123 | 128 | PF00069 | 0.536 |
MOD_CDK_SPxxK_3 | 138 | 145 | PF00069 | 0.450 |
MOD_CK1_1 | 205 | 211 | PF00069 | 0.484 |
MOD_CK1_1 | 51 | 57 | PF00069 | 0.658 |
MOD_GlcNHglycan | 204 | 207 | PF01048 | 0.595 |
MOD_GlcNHglycan | 50 | 53 | PF01048 | 0.725 |
MOD_GlcNHglycan | 74 | 77 | PF01048 | 0.301 |
MOD_GlcNHglycan | 96 | 100 | PF01048 | 0.348 |
MOD_N-GLC_1 | 133 | 138 | PF02516 | 0.564 |
MOD_N-GLC_1 | 190 | 195 | PF02516 | 0.497 |
MOD_NEK2_1 | 114 | 119 | PF00069 | 0.603 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.578 |
MOD_PKA_2 | 144 | 150 | PF00069 | 0.501 |
MOD_Plk_1 | 133 | 139 | PF00069 | 0.508 |
MOD_Plk_4 | 114 | 120 | PF00069 | 0.525 |
MOD_ProDKin_1 | 123 | 129 | PF00069 | 0.564 |
MOD_ProDKin_1 | 138 | 144 | PF00069 | 0.500 |
MOD_ProDKin_1 | 176 | 182 | PF00069 | 0.505 |
TRG_ENDOCYTIC_2 | 174 | 177 | PF00928 | 0.438 |
TRG_ENDOCYTIC_2 | 90 | 93 | PF00928 | 0.500 |
TRG_ER_diArg_1 | 164 | 167 | PF00400 | 0.466 |
TRG_ER_diArg_1 | 212 | 215 | PF00400 | 0.536 |
TRG_ER_diArg_1 | 85 | 87 | PF00400 | 0.501 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IM50 | Leptomonas seymouri | 86% | 100% |
A0A0S4JT34 | Bodo saltans | 60% | 100% |
A0A1X0NUY5 | Trypanosomatidae | 70% | 100% |
A0A3Q8IT45 | Leishmania donovani | 96% | 100% |
A0A3R7KPL2 | Trypanosoma rangeli | 72% | 100% |
A4HK56 | Leishmania braziliensis | 89% | 100% |
A4I7P2 | Leishmania infantum | 96% | 100% |
D0A9U3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 71% | 90% |
D0A9U5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 71% | 84% |
E9B2J9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |